Stojanović, M.; Bursać, D. Immunotoxicity of Pembrolizumab in Patients With Metastatic Non-Small Cell Lung Cancer: A Single-Centre Study. Arch Oncol 2024, 30 (1), 14-18. https://doi.org/10.2298/AOO240304006S.